Low plasma levels of SHBG are associated with several sex-steroid hormone-dependent diseases [109] and have been reported to be an early indicator of cardiovascular risk in individuals suffering from obesity and metabolic syndrome [110–112]. This evidence concerns the gene SHBG and obesity due to melanocortin 4 receptor deficiency.